Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
CGM use less likely for children with type 1 diabetes living in rural vs. urban areas
Children with type 1 diabetes living in small or isolated rural towns are less likely to use continuous glucose monitoring than those living in urban areas, according to data published in Diabetes Care.
Mean HbA1c declines for people with type 1 diabetes from 2016 to 2022
Mean HbA1c for children and adults with type 1 diabetes improved by 0.3 percentage points from 2016 to 2022, according to data from 15 clinics participating in the T1D Exchange Quality Improvement Collaborative.
Log in or Sign up for Free to view tailored content for your specialty!
CDC launches new public service announcements as part of prediabetes awareness initiative
The CDC has announced the launch of new public service announcements as part of its ongoing “Do I Have Prediabetes?” initiative to encourage people to learn about prediabetes diagnosis and risks.
SGLT2 inhibitors ‘substantially’ reduce gout risk in patients with type 2 diabetes
SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.
Type 2 diabetes associated with higher risk for colorectal cancer
Risk for developing colorectal cancer increased by 47% among individuals with type 2 diabetes, according to results from a cohort study designed to over-represent African Americans and low-income patients.
Gender gap in life expectancy widens amid COVID-19, drug overdose crisis
The gender gap in life expectancy in the United States has grown in recent years, with women living nearly 6 years longer than men on average, according to the results of a study published in JAMA Internal Medicine.
In acute MI, dapagliflozin confers cardiometabolic benefit, in absence of diabetes, HF
PHILADELPHIA — In patients without diabetes or heart failure presenting with acute MI and impaired left ventricular function, dapagliflozin improved cardiometabolic outcomes compared with placebo, according to the DAPA-MI trial.
Semaglutide cuts cardiovascular risk by 20% in people with heart disease, obesity: SELECT
PHILADELPHIA — In the SELECT trial, treatment with weekly injectable semaglutide 2.4 mg was superior to placebo for reducing cardiovascular risk in adults with preexisting heart disease and overweight or obesity but without diabetes.
Diabetes linked to poorer survival after nephrectomy for renal cell carcinoma
NASHVILLE, Tenn. — Diabetes appeared linked to shorter survival among patients who underwent nephrectomy for renal cell carcinoma, according to study results presented at International Kidney Cancer Symposium: North America.
Cost of diabetes care in US rises to $412.9 billion in 2022
The total annual cost of caring for Americans with diabetes in 2022 was an estimated $412.9 billion, and one in four total health care dollars in the U.S. went toward diabetes care, according to a report.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read